CSPG4 and melanoma: The expression pattern of CSPG4 combined with putative roles in multiple oncogenic and treatment resistance-promoting pathways render this a promising target for cancer therapies that are designed to inhibit its pro-tumour functions or focus immune responses against CSPG4-expressing melanomas.